Diaxonhit’s €28.9 million acquisition of Capforce Plus (Eurobio)

Paolo Bossi

Jones Day has advised Diaxonhit, a French biotechnology company listed on Alternext and specialized in in vitro diagnostics, in connection with its acquisition of Capforce Plus…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now